Breaking
Novo Nordisk Launches Wegovy in China Before Eli Lilly, Capturing World's Largest Obesity MarketVanda Pharmaceuticals Launches NEREUS (Tradipitant) - First New Motion Sickness Drug in 40+ Years Now AvailableTakeda's TAK-881 Meets Primary Endpoint in Phase 2/3 Trial for Primary Immunodeficiency Disease
🇺🇸 FDA

Securities

Page 1 • 1 item

Track global pharma securities, IPOs, M&A, and investor insights. Essential intelligence for pharmaceutical investment and business development.